tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Iterum Therapeutics’ Earnings Call: Optimism Amid Challenges
PremiumCompany AnnouncementsIterum Therapeutics’ Earnings Call: Optimism Amid Challenges
2M ago
Buy Rating for Iterum Therapeutics: Strategic Positioning and Growth Potential with ORLYNVAH Launch
Premium
Ratings
Buy Rating for Iterum Therapeutics: Strategic Positioning and Growth Potential with ORLYNVAH Launch
2M ago
Iterum Therapeutics Prepares for ORLYNVAH™ Launch
Premium
Company Announcements
Iterum Therapeutics Prepares for ORLYNVAH™ Launch
2M ago
Iterum Therapeutics appoints Coyne as CCO
PremiumThe FlyIterum Therapeutics appoints Coyne as CCO
3M ago
Iterum Therapeutics announces publication of REASSURE trial in NEJM Evidence
Premium
The Fly
Iterum Therapeutics announces publication of REASSURE trial in NEJM Evidence
3M ago
Iterum Therapeutics: Strategic Positioning and Growth Potential with ORLYNVAH Launch
Premium
Ratings
Iterum Therapeutics: Strategic Positioning and Growth Potential with ORLYNVAH Launch
3M ago
Iterum Therapeutics’ Earnings Call: Progress Amid Challenges
PremiumCompany AnnouncementsIterum Therapeutics’ Earnings Call: Progress Amid Challenges
4M ago
Buy Rating for Iterum Therapeutics: Strategic Positioning and Market Opportunities for Orlynvah
Premium
Ratings
Buy Rating for Iterum Therapeutics: Strategic Positioning and Market Opportunities for Orlynvah
4M ago
Iterum Therapeutics Prepares for ORLYNVAH™ Launch
Premium
Company Announcements
Iterum Therapeutics Prepares for ORLYNVAH™ Launch
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100